IDEXX Cost Of Revenue from 2010 to 2024
IDXX Stock | USD 479.57 3.22 0.68% |
Cost Of Revenue | First Reported 1991-06-30 | Previous Quarter 367.5 M | Current Value 375.4 M | Quarterly Volatility 104.2 M |
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.7 M, Interest Expense of 37.7 M or Total Revenue of 3.8 B, as well as many exotic indicators such as Price To Sales Ratio of 13.22, Dividend Yield of 0.0013 or PTB Ratio of 32.61. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
IDEXX | Cost Of Revenue |
Latest IDEXX Laboratories' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of IDEXX Laboratories over the last few years. Cost of Revenue is found on IDEXX Laboratories income statement and represents the costs associated with goods and services IDEXX Laboratories provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is IDEXX Laboratories' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
Timeline |
IDEXX Cost Of Revenue Regression Statistics
Arithmetic Mean | 913,679,477 | |
Geometric Mean | 690,953,628 | |
Coefficient Of Variation | 45.15 | |
Mean Deviation | 327,646,242 | |
Median | 871,676,000 | |
Standard Deviation | 412,495,503 | |
Sample Variance | 170152.5T | |
Range | 1.5B | |
R-Value | 0.97 | |
Mean Square Error | 11334.3T | |
R-Squared | 0.94 | |
Slope | 89,338,629 | |
Total Sum of Squares | 2382135.6T |
IDEXX Cost Of Revenue History
About IDEXX Laboratories Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include IDEXX Laboratories income statement, its balance sheet, and the statement of cash flows. IDEXX Laboratories investors use historical funamental indicators, such as IDEXX Laboratories's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although IDEXX Laboratories investors may use each financial statement separately, they are all related. The changes in IDEXX Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IDEXX Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on IDEXX Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Cost Of Revenue | 1.5 B | 1.5 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of IDEXX Laboratories Correlation against competitors. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.121 | Earnings Share 10.07 | Revenue Per Share 44.073 | Quarterly Revenue Growth 0.088 | Return On Assets 0.2283 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.